13F

Stock

Acurx Pharmaceuticals, Inc.

ACXP · held by 22 managers

Reported value

$605.2K

Holders

22

+6 new · −3 exited

Holders’ est. mark

$59.5K

Price effect on 14 books still in the name

Largest holder

$202.7K

JANE STREET GROUP, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
JANE STREET GROUP, LLC54.6K$202.7K$13.1KAdded$176K
VANGUARD CAPITAL MANAGEMENT LLC31.1K$115.4KHeld
GEODE CAPITAL MANAGEMENT, LLC24.8K$92.1K$15.1KAdded$61.2K
VANGUARD FIDUCIARY TRUST CO16.2K$60.1KHeld
Prospect Financial Services LLC13.8K$51.1K$16.8KAdded$1.76K
MORGAN STANLEY6.5K$24.1K$7.93KAdded$7.93K
UBS Group AG6.31K$23.4K$207Added$23K
WELLS FARGO & COMPANY/MN2.3K$8.53K$2.81KAdded$2.81K
Westside Investment Management, Inc.1.65K$6.12KNew
NBC SECURITIES, INC.1.5K$5.57K$1.83KAdded$1.83K
Western Wealth Management, LLC1.32K$4.92KNew
Tower Research Capital LLC (TRC)1.03K$3.83K$1.26KCut−$3.36K
MCGUIRE CAPITAL ADVISORS INC1K$3.71KNew
BARCLAYS PLC380$1.41KNew
GROUP ONE TRADING LLC245$909$299Added$204
OSAIC HOLDINGS, INC.100$371$122Added$122
Cornerstone Planning Group LLC167$334−$99Cut−$99
BlackRock, Inc.60$223$74Added$74
Advisory Services Network, LLC59$219New
Cambridge Investment Research Advisors, Inc.20K$74New
SBI Securities Co., Ltd.6$22$7Cut−$10
CITIGROUP INC1$4$2Added$2

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.